drugset / Trial / NCT03067181
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
RandomizedParallel-groupOpen-labelTreatment
Summary
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Timeline
- Start
- 2017-05-25
- Primary completion
- 2027-06-30
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | Intravenous |
| Subject | Cisplatin | Other / unclassified | — | Intravenous |
| Background | Bleomycin | Unknown | — | Intravenous |
| Background | Etoposide | Small molecule | — | Intravenous |
Indications
childhood germ cell tumor
choriocarcinoma of ovary
choriocarcinoma of testis
malignant teratoma
mixed testicular germ cell cancer
non-central nervous system-localized embryonal carcinoma
ovarian embryonal carcinoma
ovarian yolk sac tumor
testicular embryonal carcinoma
testicular seminoma
testicular yolk sac tumor